FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hideo Yoshida

Research Profile

Living Beings

Disorders

Anatomy

Tumor Cells, Cultured

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ryosuke Tateishi; Shuichiro Shiina; Takamasa Ohki; Takahisa Sato; Ryota Masuzaki; Jun Imamura; Eriko Goto; Tadashi Goto; Hideo Yoshida; Shuntaro Obi; Shinpei Sato; Fumihiko Kanai; Haruhiko Yoshida; Masao Omata
Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation.
Miho Kanda; Ryosuke Tateishi; Hideo Yoshida; Takahisa Sato; Ryota Masuzaki; Takamasa Ohki; Jun Imamura; Tadashi Goto; Haruhiko Yoshida; Keisuke Hamamura; Shuntaro Obi; Fumihiko Kanai; Shuichiro Shiina; Masao Omata
Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.
Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Hideo Yoshida; Shinpei Sato; Naoya Kato; Fumihiko Kanai; Yosuke Sugioka; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hideo Yoshida (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Ryosuke Tateishi; Shuichiro Shiina; Takamasa Ohki; Takahisa Sato; Ryota Masuzaki; Jun Imamura; Eriko Goto; Tadashi Goto; Hideo Yoshida; Shuntaro Obi; Shinpei Sato; Fumihiko Kanai; Haruhiko Yoshida; Masao Omata
Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation.
Journal of gastroenterology 2009;44 Suppl 19():142-6.
2008: Miho Kanda; Ryosuke Tateishi; Hideo Yoshida; Takahisa Sato; Ryota Masuzaki; Takamasa Ohki; Jun Imamura; Tadashi Goto; Haruhiko Yoshida; Keisuke Hamamura; Shuntaro Obi; Fumihiko Kanai; Shuichiro Shiina; Masao Omata
Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(9):1256-63.
2008: Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Hideo Yoshida; Shinpei Sato; Naoya Kato; Fumihiko Kanai; Yosuke Sugioka; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography.
Journal of clinical gastroenterology 2008;42(7):839-43.
2008: Takamasa Ohki; Ryosuke Tateishi; Takahisa Sato; Ryota Masuzaki; Jun Imamura; Tadashi Goto; Noriyo Yamashiki; Haruhiko Yoshida; Fumihiko Kanai; Naoya Kato; Shuichiro Shiina; Hideo Yoshida; Takao Kawabe; Masao Omata
Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(4):459-64.
2008: Hideo Yoshida; Haruhiko Yoshida; Eriko Goto; Takahisa Sato; Takamasa Ohki; Ryota Masuzaki; Ryosuke Tateishi; Tadashi Goto; Shuichiro Shiina; Takao Kawabe; Masao Omata
Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma.
Hepatology international 2008;2(1):89-94.
2007: Noriyo Yamashiki; Haruhiko Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Takuma Teratani; Hideo Yoshida; Yuji Kondo; Takamasa Oki; Takao Kawabe; Masao Omata
Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment.
Journal of gastroenterology and hepatology 2007;22(12):2155-60.
2007: Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Takahisa Sato; Takamasa Ohki; Tadashi Goto; Hideo Yoshida; Shinpei Sato; Yosuke Sugioka; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Assessing liver tumor stiffness by transient elastography.
Hepatology international 2007;1(3):394-7.
2007: Shuichiro Shiina; Ryosuke Tateishi; Hideo Yoshida; Fumihiko Kanai; Masao Omata
Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation.
Saudi medical journal 2007;28(6):831-7.
2007: Takamasa Ohki; Ryosuke Tateishi; Shuichiro Shiina; Takahisa Sato; Ryota Masuzaki; Hideo Yoshida; Fumihiko Kanai; Shuntaro Obi; Haruhiko Yoshida; Masao Omata
Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(3):360-7.
2007: Yuji Kondo; Hideo Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Norio Mine; Noriyo Yamashiki; Shinpei Sato; Naoya Kato; Fumihiko Kanai; Mikio Yanase; Haruhiko Yoshida; Masatoshi Akamatsu; Takuma Teratani; Takao Kawabe; Masao Omata
Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma.
Journal of gastroenterology and hepatology 2007;22(2):197-203.
2006: Ryosuke Tateishi; Shuichiro Shiina; Haruhiko Yoshida; Takuma Teratani; Shuntaro Obi; Noriyo Yamashiki; Hideo Yoshida; Masatoshi Akamatsu; Takao Kawabe; Masao Omata
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Hepatology (Baltimore, Md.) 2006;44(6):1518-27.
2006: Wataru Shibata; Yoshihiro Hirata; Shingo Maeda; Keiji Ogura; Tomoya Ohmae; Ayako Yanai; Yuzo Mitsuno; Yutaka Yamaji; M Okamoto; Hideo Yoshida; Takao Kawabe; Masao Omata
CagA protein secreted by the intact type IV secretion system leads to gastric epithelial inflammation in the Mongolian gerbil model.
The Journal of pathology 2006;210(3):306-14.
2005: Hideo Yoshida; Haruhiko Yoshida; Shuichiro Shiina; Masao Omata
Early liver cancer: concepts, diagnosis, and management.
International journal of clinical oncology 2005;10(6):384-90.
2005: Yujin Hoshida; Naoya Kato; Hideo Yoshida; Yue Wang; Masamichi Tanaka; Tadashi Goto; Motoyuki Otsuka; Hiroyoshi Taniguchi; Masaru Moriyama; Fumio Imazeki; Osamu Yokosuka; Takao Kawabe; Yasushi Shiratori; Masao Omata
Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8.
The Journal of infectious diseases 2005;192(2):266-75.
2005: Hirotsugu Watabe; Toru Mitsushima; Yutaka Yamaji; Makoto Okamoto; Ryouichi Wada; T Kokubo; H Doi; Hideo Yoshida; Takao Kawabe; Masao Omata
Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.
Gut 2005;54(6):764-8.
2005: Naoki Sasahira; Minoru Tada; Hideo Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Kenji Hirano; Hiroyuki Isayama; Nobuo Toda; Yutaka Komatsu; Takao Kawabe; Masao Omata
Extrahepatic biliary obstruction after percutaneous tumour ablation for hepatocellular carcinoma: aetiology and successful treatment with endoscopic papillary balloon dilatation.
Gut 2005;54(5):698-702.
2005: Ryosuke Tateishi; Hideo Yoshida; Shuichiro Shiina; H Imamura; K Hasegawa; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Makuuchi Masatoshi; Masao Omata
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.
Gut 2005;54(3):419-25.
2004: Hiroyuki Isayama; Yutaka Komatsu; Takeshi Tsujino; Naoki Sasahira; Kenji Hirano; Nobuo Toda; Yousuke Nakai; Natsuyo Yamamoto; Minoru Tada; Hideo Yoshida; Yasushi Shiratori; Takao Kawabe; Masao Omata
A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction.
Gut 2004;53(5):729-34.
2004: Hideo Yoshida; Ryosuke Tateishi; Y Arakawa; M Sata; S Fujiyama; Shuhei Nishiguchi; H Ishibashi; G Yamada; O Yokosuka; Yasushi Shiratori; Masao Omata
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C.
Gut 2004;53(3):425-30.
2004: Hiroyoshi Taniguchi; Naoya Kato; Motoyuki Otsuka; Tadashi Goto; Hideo Yoshida; Yasushi Shiratori; Masao Omata
Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription.
Journal of medical virology 2004;72(1):52-9.
2003: Ryoichi Iiyama; Takanori Kanai; Koji Uraushihara; Takahiro Ishikura; Shin Makita; Teruji Totsuka; Motomi Yamazaki; Tetsuya Nakamura; Tatsuya Miyata; Hideo Yoshida; O Takeuchi; K Hoshino; Kiyoshi Takeda; Hiromichi Ishikawa; Shizuo Akira; Masahiko Watanabe
Normal development of the gut-associated lymphoid tissue except Peyer's patch in MyD88-deficient mice.
Scandinavian journal of immunology 2003;58(6):620-7.
2003: Hirofumi Tomiyama; Toshio Kushiro; Ryo Okazaki; Hideo Yoshida; Nobutaka Doba; Akira Yamashina
Influences of increased oxidative stress on endothelial function, platelets function, and fibrinolysis in hypertension associated with glucose intolerance.
Hypertension research : official journal of the Japanese Society of Hypertension 2003;26(4):295-300.
2003: Tadashi Goto; Naoya Kato; Hideo Yoshida; Motoyuki Otsuka; Masaru Moriyama; Yasushi Shiratori; Katsuro Koike; Masayuki Matsumura; Masao Omata
Synergistic activation of the serum response element-dependent pathway by hepatitis B virus x protein and large-isoform hepatitis delta antigen.
The Journal of infectious diseases 2003;187(5):820-8.
2003: Hirofumi Tomiyama; Gohki Watanabe; Hideo Yoshida; Nobutaka Doba; Akira Yamashina
Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.
American heart journal 2003;145(1):E2.
2003: Yue Wang; Naoya Kato; Yujin Hoshida; Hideo Yoshida; Hiroyoshi Taniguchi; Tadashi Goto; Masaru Moriyama; Motoyuki Otsuka; Shuichiro Shiina; Yasushi Shiratori; Yoichi Ito; Masao Omata
Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2003;37(1):65-71.
2002: Motoyuki Otsuka; Naoya Kato; Haruhiko Yoshida; Hideo Yoshida; Yasushi Shiratori; Masao Omata
[HCV-related hepatocellular carcinoma].
Uirusu 2002;52(2):295-300.
2002: Hideo Yoshida; Naoya Kato; Yasushi Shiratori; Runxuan Shao; Yue Wang; Shuichiro Shiina; Masao Omata
Weak association between SEN virus viremia and liver disease.
Journal of clinical microbiology 2002;40(9):3140-5.
2002: Shingo Maeda; Hideo Yoshida; Yuzo Mitsuno; Yoshihiro Hirata; Keiji Ogura; Yasushi Shiratori; Masao Omata
Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori.
Gut 2002;50(6):771-8.
2002: Motoyuki Otsuka; Naoya Kato; Hiroyoshi Taniguchi; Hideo Yoshida; Tadashi Goto; Yasushi Shiratori; Masao Omata
Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression.
Virology 2002;296(1):84-93.
2002: Yutaka Yamaji; Toru Mitsushima; Hitoshi Ikuma; Makoto Okamoto; Hideo Yoshida; Takao Kawabe; Yasushi Shiratori; Keiji Saito; Kou Yokouchi; Masao Omata
Weak response of helicobacter pylori antibody is high risk for gastric cancer: a cross-sectional study of 10,234 endoscoped Japanese.
Scandinavian journal of gastroenterology 2002;37(2):148-53.
2002: Jun Kato; Naoya Kato; Hideo Yoshida; Suzane Kioko Ono-Nita; Yasushi Shiratori; Masao Omata
Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo.
Journal of medical virology 2002;66(2):187-99.
2001: Shingo Maeda; Masao Akanuma; Yuzo Mitsuno; Yasunobu Hirata; Keiji Ogura; Hideo Yoshida; Yasushi Shiratori; Masao Omata
Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells.
The Journal of biological chemistry 2001;276(48):44856-64.
2001: Yutaka Yamaji; Toru Mitsushima; Hitoshi Ikuma; Makoto Okamoto; Hideo Yoshida; Takao Kawabe; Yasushi Shiratori; Keiji Saito; Kou Yokouchi; Masao Omata
Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects.
Gut 2001;49(3):335-40.
2001: Yasushi Shiratori; Hideo Yoshida; Masao Omata
Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention.
Expert review of anticancer therapy 2001;1(2):277-90.
2001: Shinpei Sato; Yasushi Shiratori; Masatoshi Imamura; Takuma Teratani; Shuntaro Obi; Yukihiro Koike; Yasuo Imai; Hideo Yoshida; Shuichiro Shiina; Masao Omata
Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients.
Journal of hepatology 2001;35(2):225-34.
2001: Yuzo Mitsuno; Hideo Yoshida; Shingo Maeda; Keiji Ogura; Yoshihiro Hirata; Takao Kawabe; Yasushi Shiratori; Masao Omata
Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells.
Gut 2001;49(1):18-22.
2001: Shingo Maeda; Motoyuki Otsuka; Yasunobu Hirata; Yuzo Mitsuno; Hideo Yoshida; Yasushi Shiratori; Yasuhiko Masuho; Masami Muramatsu; Naohiko Seki; Masao Omata
cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells.
Biochemical and biophysical research communications 2001;284(2):443-9.
2001: Keiji Ogura; Hideo Yoshida; Shingo Maeda; Yutaka Yamaji; Takao Kawabe; Makoto Okamoto; Yasushi Shiratori; Masao Omata
Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given?
Scandinavian journal of gastroenterology 2001;36(6):584-8.
2001: Yasunobu Hirata; Shingo Maeda; Yuzo Mitsuno; Masao Akanuma; Yutaka Yamaji; Keiji Ogura; Hideo Yoshida; Yasushi Shiratori; Masao Omata
Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells.
Infection and immunity 2001;69(6):3965-71.
2001: Hideo Yoshida; Nobumasa Kato; Yasushi Shiratori; Motoyuki Otsuka; Shingo Maeda; J Kato; Masao Omata
Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor.
The Journal of biological chemistry 2001;276(19):16399-405.
2001: Shingo Maeda; Hideo Yoshida
[Mechanism of drug resistance in Helicobacter pylori].
Nihon rinsho. Japanese journal of clinical medicine 2001;59(2):367-73.
2001: Yukihiro Koike; Yasushi Shiratori; Shinichi Sato; Shuntaro Obi; Takuma Teratani; Masatoshi Imamura; Hideo Yoshida; Shuichiro Shiina; Masao Omata
Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.
Cancer 2001;91(3):561-9.
2001: Tsuneo Ikenoue; Shingo Maeda; Keiji Ogura; Masao Akanuma; Yuzo Mitsuno; Y Imai; Hideo Yoshida; Yasushi Shiratori; Masao Omata
Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island.
Clinical and diagnostic laboratory immunology 2001;8(1):181-6.
2000: Keiji Ogura; Shingo Maeda; M Nakao; Tomomi Watanabe; M Tada; T Kyutoku; Hideo Yoshida; Yasushi Shiratori; Masao Omata
Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil.
The Journal of experimental medicine 2000;192(11):1601-10.
2000: Yukihiro Koike; Yasushi Shiratori; Shinpei Sato; Shuntaro Obi; Takuma Teratani; M Imamura; Keisuke Hamamura; Y Imai; Hideo Yoshida; Shuichiro Shiina; Masao Omata
Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion.
Hepatology (Baltimore, Md.) 2000;32(6):1216-23.
2000: Tadashi Goto; Nobumasa Kato; Suzane Kioko Ono-Nita; Hideo Yoshida; Motoyuki Otsuka; Yasushi Shiratori; Masao Omata
Large isoform of hepatitis delta antigen activates serum response factor-associated transcription.
The Journal of biological chemistry 2000;275(48):37311-6.
2000: Motoyuki Otsuka; Nobumasa Kato; K Lan; Hideo Yoshida; J Kato; Tadashi Goto; Yasushi Shiratori; Masao Omata
Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.
The Journal of biological chemistry 2000;275(44):34122-30.
2000: Nobumasa Kato; Hideo Yoshida; Suzane Kioko Ono-Nita; J Kato; Tadashi Goto; Motoyuki Otsuka; K Lan; K Matsushima; Yasushi Shiratori; Masao Omata
Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.
Hepatology (Baltimore, Md.) 2000;32(2):405-12.
2000: Yasushi Shiratori; M Moriyama; F Imazeki; Harunobu Ohkubo; N Tanaka; Y Arakawa; Hideo Yoshida; Osamu Yokosuka; A Shibuya; K Matsuzaki; Etsuko Hashimoto; Naoaki Hayashi; Koichi Hirata; Y Ohashi; Masao Omata
A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients. Tokyo-Chiba Hepatitis Research Group.
Liver 2000;20(4):271-80.
2000: Shingo Maeda; Hideo Yoshida; Keiji Ogura; Yuzo Mitsuno; Yasunobu Hirata; Yutaka Yamaji; Masao Akanuma; Yasushi Shiratori; Masao Omata
H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells.
Gastroenterology 2000;119(1):97-108.
2000: Hideo Yoshida; Nobumasa Kato; Yasushi Shiratori; KH Lan; Suzane Kioko Ono-Nita; Z Feng; Shuichiro Shiina; Masao Omata
Poor association of TT virus viremia with hepatocellular carcinoma.
Liver 2000;20(3):247-52.
2000: Keisuke Hamamura; Yasushi Shiratori; Shuichiro Shiina; Masatoshi Imamura; Shuntaro Obi; Shinichi Sato; Hideo Yoshida; Masao Omata
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.
Cancer 2000;88(7):1557-64.
2000: S Maeda; Hideo Yoshida; K Ogura; Yutaka Yamaji; T Ikenoue; Toru Mitsushima; H Tagawa; R Kawaguchi; K Mori; Ken-ichi Mafune; Takao Kawabe; Yasushi Shiratori; Masao Omata
Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.
Cancer 2000;88(7):1530-5.
2000: Hideo Yoshida; K Hirota; Keiji Ogura; Shin Maeda; Yasushi Shiratori; Y Sasaki; Masao Omata
Determination of the optimal cut-off value for the [13C]-urea breath test based on a Helicobacter pylori-specific polymerase chain reaction assay.
Journal of gastroenterology and hepatology 2000;15(2):155-60.
2000: Shingo Maeda; Hideo Yoshida; H Matsunaga; Keiji Ogura; O Kawamata; Yasushi Shiratori; Masao Omata
Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay.
Journal of clinical microbiology 2000;38(1):210-4.
1999: Suzane Kioko Ono-Nita; Nobumasa Kato; Yasushi Shiratori; KH Lan; Hideo Yoshida; Flair Jose Carrilho; Masao Omata
Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.
The Journal of clinical investigation 1999;103(12):1635-40.
1999: Shingo Maeda; Hideo Yoshida; T Ikenoue; Keiji Ogura; Fumihiko Kanai; N Kato; Yasushi Shiratori; Masao Omata
Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates.
Gut 1999;44(3):336-41.
1999: Hideo Yoshida; Shingo Maeda; Keiji Ogura
[PCR-monitoring of gastric juice obtained with the capsuled string for the evaluation of H. pylori eradication].
Nihon rinsho. Japanese journal of clinical medicine 1999;57(1):107-10.
1999: Shingo Maeda; Hideo Yoshida
[Detection of Helicobacter pylori 23S rRNA gene mutation associated with clarithromycin resistance and its clinical applicability].
Nihon rinsho. Japanese journal of clinical medicine 1999;57(1):87-92.
1999: Yasushi Shiratori; Nobumasa Kato; Hideo Yoshida; F Imazeki; K Okano; O Yokosuka; Masao Omata
How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? Tokyo-Chiba Hepatitis Research Group.
Journal of gastroenterology and hepatology 1999;14(1):79-84.
1998: Shingo Maeda; Hideo Yoshida; Keiji Ogura; Fumihiko Kanai; Yasushi Shiratori; Masao Omata
Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance.
Gut 1998;43(3):317-21.
1998: Hideo Yoshida; Akira Watanabe; Yasuo Ihara
Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease.
The Journal of biological chemistry 1998;273(16):9761-8.
1998: M Ohashi; Fumihiko Kanai; Toshihiro Tanaka; KH Lan; Yasushi Shiratori; Y Komatsu; Takao Kawabe; Hideo Yoshida; Hirofumi Hamada; Masao Omata
In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer.
Japanese journal of cancer research : Gann 1998;89(4):457-62.
1998: Shingo Maeda; Keiji Ogura; Hideo Yoshida; Fumihiko Kanai; T Ikenoue; N Kato; Yasushi Shiratori; Masao Omata
Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan.
Gut 1998;42(3):338-43.
1998: Hideo Yoshida; K Hirota; Yasushi Shiratori; T Nihei; S Amano; A Yoshida; O Kawamata; Masao Omata
Use of a gastric juice-based PCR assay to detect Helicobacter pylori infection in culture-negative patients.
Journal of clinical microbiology 1998;36(1):317-20.
1997: Keiji Ogura; Fumihiko Kanai; Shingo Maeda; Hideo Yoshida; M Ogura; KH Lan; K Hirota; Takao Kawabe; Yasushi Shiratori; Masao Omata
High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan.
Gut 1997;41(4):463-8.
1996: K Yoshikawa; Kazuyuki Tobe; Naoki Yoshioka; Hideo Yoshida
[MR imaging and dynamic MR imaging].
Nihon rinsho. Japanese journal of clinical medicine 1996;54(5):1255-62.